Seek, Find, and Treat: Best Practices for Managing Patients with Transthyretin Amyloid Polyneuropathy (ATTR-PN)
October 29, 2025
In this program, experts Drs. Morie Gertz, Michelle Mauermann, Sami Khella, and Ronald Witteles will describe best practices for the diagnosis, treatment, and monitoring of disease progression in these patients.
CME 1.00 Credits In-Progress
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure: New Opportunities to Improve Patient Outcomes
October 08, 2025
In this symposium, Chair Dr. Mathew Maurer, and faculty members Dr. Noel Dasgupta, Dr. Omar Abou Ezzeddine, and Dr. Frederick Ruberg, will explain best practices for screening and diagnosing ATTR-CM in patients with concomitant HF, describe the treatment landscape, and, through case presentation, discuss practical considerations in management.
CME 1.25 Credits In-Progress
Clinical Clues, Diagnostic Pearls, and a Changing Therapeutic Landscape: Optimizing the Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure
July 30, 2025
In this symposium, three experts in ATTRCM (Dr. Mathew Maurer, Dr. Sarah Cuddy, and Dr. Melissa Lyle) will explain best practices for identifying and diagnosing ATTR-CM in patients with concomitant HF, describe the evidence for current ATTR-CM therapies and, through case presentation, discuss practical considerations in management.
CME 1.00 Credits In-Progress
Managing Hyperkalemia in Heart Failure: Implementing Strategies to Reduce Patient Risk
July 29, 2025
In this symposium, attendees will be provided with best practices by a multidisciplinary faculty on the prevention of hyperkalemia, identification of patients at risk for hyperkalemia, the importance of maintaining HF patients on RAASis and preferably at target doses, recent clinical evidence with novel potassium binders, and strategies for effective communication with patients.
CME 1.00 Credits In-Progress
Best Practices for Managing Intracerebral Hemorrhage
May 20, 2025
In this symposium, experts in ICH management will discuss the clinical evidence for blood pressure control and DOAC reversal and provide illustrative case studies. Results of studies focusing on bundles of care will be summarized, and faculty members will provide insights for an adoption of this strategy to improve patient outcomes.
CME Credit Obtained Off Site
Addressing Challenges: Best Practices for DOAC Reversal in Intracranial Hemorrhage
October 30, 2024
In this symposium, an expert multidisciplinary faculty will provide insights into and interpretations of clinical data, and challenging cases will reinforce key elements of prudent management of major bleeding in patients taking DOACs and experiencing intracranial hemorrhage.
No Credit Available
Improving Outcomes of Patients With Transthyretin Amyloid Polyneuropathy (ATTR-PN)
October 14, 2024
In this program, ATTR-PN experts (chair Dr. Morie Gertz, and faculty members Dr. Amanda Peltier and Dr. Michelle Mauermann) will present, through lectures and “realworld” case studies, current evidence and best practices for management of ATTR-PN.
No Credit Available
Managing Worsening Heart Failure with Reduced Ejection Fraction: Strategies for Successful Outcomes
August 04, 2024
In this educational initiative, the current definition and clinical impact of WHF will be described, and principles of management explained.
No Credit Available
Navigating the Complexities of Recognizing, Diagnosing and Treating Transthyretin Amyloid Polyneuropathy (ATTR-PN)
October 31, 2023
In this program, ATTR-PN experts (Chair Dr. Sami Khella, and faculty members Dr. Morie Gertz and Dr. Amanda Peltier) will describe the signs, symptoms, hereditability, and other factors that indicate possible ATTR-PN. The diagnostic process will be explained, and data with currently available and emerging therapies will be discussed.
No Credit Available
DOACs and Intracranial Hemorrhage: Best Practices to Optimize Outcomes
October 15, 2023
In this program, Program Chair Dr. Joshua Goldstein and an expert multidisciplinary faculty (Dr. Casey May, Dr. Anne Alexandrov, and Dr. Ashkan Shoamanesh) will provide attendees with best practices for optimal management of intracranial hemorrhage.
No Credit Available
Anticoagulant Reversal in Stroke: Best Practices for Successful Outcomes
March 12, 2023
This program will focus on why clinicians must have a greater recognition of the risks and potential consequences of anticoagulant reversal in patients receiving anticoagulant therapies and the treatment algorithms for initiating reversal therapy in the diverse and expanding patient populations who use anticoagulants.
No Credit Available
The Integral Role of Nephrology Nurses in the Management of Hyperkalemia
September 18, 2022
In this program, experts in the management of hyperkalemia will 1) identify goals and strategies in managing acute and chronic hyperkalemia, 2) emphasize the importance of maintaining CKD patients on RAASi to improve clinical outcomes, 3) interpret the evidence with new potassium binders in the treatment of patients with hyperkalemia with CKD and also with ESRD undergoing hemodialysis, and 4) explain how to best use these new therapies in clinical practice
No Credit Available